Skip to main content

Table 9 Opinion of the scientific steering committee – clozapine resistance

From: Place of the partial dopamine receptor agonist aripiprazole in the management of schizophrenia in adults: a Delphi consensus study

• Augmentation with aripiprazole should be considered in patients with TRS treated with clozapine in case of persistence of symptoms; this is of interest when negative symptoms persist

• Augmentation with aripiprazole should be attempted even in patients who did not respond to aripiprazole monotherapy prior to clozapine treatment